Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04815720
Title Pepinemab in Combination With Pembrolizumab in Advanced, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (KEYNOTE B84)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Vaccinex Inc.
Indications

head and neck squamous cell carcinoma

oropharynx cancer

laryngeal squamous cell carcinoma

oral cavity cancer

hypopharynx cancer

Therapies

Pembrolizumab + Pepinemab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.